Rajesh Bhushan, secretary, Ministry of Health Lead is a pernicious...
Category:
Health
Latest
Apollo to set up more genomics institutes by 2023-end
Genomics is a field of biology focused on studying all the DNA of a...
“Today, we are in a position to service more than 60% of our policyholders entirely digitally”
Krishnan Ramachandran,MD and CEO, Niva Bupa Health Insurance Niva...
Hackers target groups in COVID-19 vaccine distribution, says IBM
IBM’s cybersecurity unit said it had detected an advanced group of hackers working to gather information about different aspects of the cold chain, using meticulously crafted booby-trapped emails sent in the name of an executive with Haier Biomedical, a Chinese cold chain provider that specializes in vaccine transport and biological sample storage.
IMA calls for strike on Dec 11 over ayurveda surgery move
Stating that the notification by the Central Council of Indian Medicine to allow the legal practice of surgeries by Ayurveda practitioners and the formation of four committees by Niti Aayog for the integration of all systems of medicine will only lead to “mixopathy”, the IMA demanded an immediate withdrawal of both.
The Union government told the Supreme Court that Ayurveda, unani and homoeopathy practitioners can prescribe drugs for prevention of Covid-19 by boosting immunity but cannot claim that their medicines can cure such patients.
Mental health in the workplace, saved by bots and apps?
Seven in 10 employees say this has been the most stressful year of their working lives, according to a report from Workplace Intelligence and Oracle.
For companies, that means the mental-health issues of employees have rocketed from a secondary concern in years past, to a primary one. But making help available, quickly and at scale, is no easy task.
And 68% say that they would prefer interacting with a robot on issues like stress and anxiety, as opposed to a human manager.
On World AIDS Day, South Africa finds hope in new treatment
In her World AIDS Day message, UNAIDS executive director Winnie Byanyima lamented the fact that more than 12 million people are still waiting to get on HIV treatment, while 1.7 million people were infected with HIV in 2019 because of lack of access.
She called on companies to “openly share their technology and know-how and to waive their intellectual property rights” so that the world can produce vaccines, including for Covid-19, at the scale required. There is no vaccine for HIV.
COVID-19 caseload breaches 95-lakh mark,death toll climbs to 1,38,648 with 526 new fatalities
The number of people who have recuperated from the disease surged to 89,73,373 pushing the national recovery rate to 94.11 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The active COVID-19 caseload continued to remain below 5 lakh.There are 4,22,943 active coronavirus infections in the country which comprises 4.44 per cent of the total caseload, the data stated.
Committed to engaging with Indian govt to bring Covid-19 vaccine: Pfizer
“During this pandemic phase, Pfizer will supply this vaccine only through government contracts based on agreements with respective government authorities and following regulatory authorisation or approval,” the statement said.
Facebook bans false claims about COVID-19 vaccines
“This could include false claims about the safety, efficacy, ingredients or side effects of the vaccines. For example, we will remove false claims that COVID-19 vaccines contain microchips,” the company said in a blog post. It said it would update the claims it removes based on evolving guidance from public health authorities.
U.S. employers could mandate a COVID-19 vaccine, but are unlikely to do so – experts
“Companies could theoretically issue a mandate, but in the current political climate it is very unlikely they will do so,” said Peter Meyers, a law professor at George Washington University Law School. “Americans tend to shy away from mandates.”
Moderna to supply up to 125 million COVID-19 vaccine doses globally in first quarter
Results from an early-stage trial showed that the vaccine, mRNA-1273, produced high levels of binding and neutralizing antibodies that declined slightly over time, but remained elevated in all participants three months after the booster vaccination, the company said
U.S. plans for first COVID vaccines as pandemic deaths surge again
“Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people’s arms,” Moncef Slaoui, a former GlaxoSmithKline executive who is overseeing the vaccine portion of the U.S. program, said at an event conducted by The Washington Post newspaper